Literature DB >> 35834068

Bioinformatic analysis identifies epidermal development genes that contribute to melanoma progression.

Gastón Barbero1, María Victoria Castro1, María Josefina Quezada1, Pablo Lopez-Bergami2.   

Abstract

Several diagnostic and prognostic markers for melanoma have been identified in last few years. However, their actual contribution to melanoma progression have not been investigated in detail. This study was aimed to identify genes, biological processes, and signaling pathways implicated in melanoma progression by applying bioinformatics analysis. We identified nine differentially expressed genes (DEGs) (IL36RN, KRT6A, KRT6B, KRT16, S100A7, SPRR1A, SPRR1B, SPRR2B, and KLK7) that were upregulated in primary melanoma compared with metastatic melanoma in all five datasets analyzed. All these genes except IL36RN, both form a protein-protein interaction network and have cellular functions associated with constitutive processes of keratinocytes. Thus, they were generically termed Epidermal Development and Cornification (EDC) genes. The differential expression of these genes in primary and metastatic melanoma was confirmed in the TCGA-SKCM cohort. High expression of the EDC genes correlated with reduced tumor thickness in primary melanoma and shorter survival in metastatic melanoma. Analysis of DEGs from primary melanoma patients displaying high or low expression of all eight EDC revealed that the upregulated genes are enriched in biological process related to cell migration, extracellular matrix organization, invasion, and Epithelial-Mesenchymal Transition. Further analysis of enriched curated oncogenic genesets together with RPPA data of phosphorylated proteins revealed the activation of MEK, ATF2, and EGFR pathways in tumors displaying high expression of EDC genes. Thus, EDC genes may contribute to melanoma progression by promoting the activation of MEK, ATF2, and EGFR pathways together with biological processes associated with tumor aggressiveness.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  EMT; Invasion; Keratinocyte development; Melanoma; Metastasis; Migration; Wnt5a

Mesh:

Substances:

Year:  2022        PMID: 35834068     DOI: 10.1007/s12032-022-01734-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.738


  41 in total

Review 1.  Keratins in health and cancer: more than mere epithelial cell markers.

Authors:  V Karantza
Journal:  Oncogene       Date:  2010-10-04       Impact factor: 9.867

Review 2.  Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia.

Authors:  Hermann H Bragulla; Dominique G Homberger
Journal:  J Anat       Date:  2009-04       Impact factor: 2.610

3.  Structural and transglutaminase substrate properties of the small proline-rich 2 family of cornified cell envelope proteins.

Authors:  E Tarcsa; E Candi; T Kartasova; W W Idler; L N Marekov; P M Steinert
Journal:  J Biol Chem       Date:  1998-09-04       Impact factor: 5.157

4.  Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.

Authors:  Shailender Bhatia; Barry E Storer; Jayasri G Iyer; Ata Moshiri; Upendra Parvathaneni; David Byrd; Arthur J Sober; Vernon K Sondak; Jeffrey E Gershenwald; Paul Nghiem
Journal:  J Natl Cancer Inst       Date:  2016-05-31       Impact factor: 13.506

5.  Sustained Secretion of the Antimicrobial Peptide S100A7 Is Dependent on the Downregulation of Caspase-8.

Authors:  Tanay Bhatt; Aishwarya Bhosale; Bhavya Bajantri; Mruthyunjaya Swamy Mathapathi; Abrar Rizvi; Giorgio Scita; Amitabha Majumdar; Colin Jamora
Journal:  Cell Rep       Date:  2019-11-26       Impact factor: 9.423

6.  Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum.

Authors:  Simon J de Veer; Laetitia Furio; Joakim E Swedberg; Christopher A Munro; Maria Brattsand; Judith A Clements; Alain Hovnanian; Jonathan M Harris
Journal:  J Invest Dermatol       Date:  2016-09-30       Impact factor: 8.551

Review 7.  Current state of melanoma diagnosis and treatment.

Authors:  Lauren E Davis; Sara C Shalin; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2019-08-01       Impact factor: 4.742

8.  Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma.

Authors:  Li-Xin Wang; Yang Li; Guan-Zhi Chen
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

9.  Screening and identification of potential prognostic biomarkers in metastatic skin cutaneous melanoma by bioinformatics analysis.

Authors:  Zufeng Sheng; Wei Han; Biao Huang; Guoliang Shen
Journal:  J Cell Mol Med       Date:  2020-09-01       Impact factor: 5.310

Review 10.  Systemic Therapy of Metastatic Melanoma: On the Road to Cure.

Authors:  Julian Steininger; Frank Friedrich Gellrich; Alexander Schulz; Dana Westphal; Stefan Beissert; Friedegund Meier
Journal:  Cancers (Basel)       Date:  2021-03-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.